Literature DB >> 11312366

Transfer of primer binding site-mutated simian immunodeficiency virus vectors by genetically engineered artificial and hybrid tRNA-like primers.

A C Hansen1, T Grunwald, A H Lund, A Schmitz, M Duch, K Uberla, F S Pedersen.   

Abstract

Simian immunodeficiency viruses (SIV) harbor primer binding sites (PBS) matching tRNA or tRNA. To study determinants of primer usage in SIV, a SIVmac239-based vector was impaired by mutating the PBS to a sequence (PBS-X2) with no match to any tRNA. By cotransfection of a synthetic gene encoding a tRNA(Pro)-like RNA with a match to PBS-X2, the activity of this vector could be restored to a transduction efficiency slightly lower than that of the wild-type vector. A vector with a PBS matching tRNA(Pro) was functional at a level slightly below that of the wild-type vector, but higher transduction efficiency could be obtained by cotransfection of a gene for an engineered tRNA(Pro)-tRNA hybrid with a match to PBS-Pro. The importance of tRNA backbone identity was further analyzed by complementing the PBS-X2 vector with a gene for a matching x2 primer with a tRNA backbone, which led to three- to fourfold-higher titers than those observed for the x2 primer with the tRNA(Pro) backbone. In summary, our results demonstrate flexibility in PBS and primer usage for SIVmac239, with PBS-primer complementarity being the major determinant, in analogy with previous findings for murine leukemia viruses and human immunodeficiency virus type 1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312366      PMCID: PMC114249          DOI: 10.1128/JVI.75.10.4922-4928.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.

Authors:  Y X Feng; S Campbell; D Harvin; B Ehresmann; C Ehresmann; A Rein
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  Identification of a novel human tRNA(Ser(CGA)) functional in murine leukemia virus replication.

Authors:  A H Lund; A Schmitz; F S Pedersen; M Duch
Journal:  Biochim Biophys Acta       Date:  2000-06-21

3.  The primer tRNA for Moloney murine leukemia virus DNA synthesis. Nucleotide sequence and aminoacylation of tRNAPro.

Authors:  F Harada; G G Peters; J E Dahlberg
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

4.  Identification of a human immunodeficiency virus type 1 that stably uses tRNALys1,2 rather than tRNALys,3 for initiation of reverse transcription.

Authors:  S M Kang; Z Zhang; C D Morrow
Journal:  Virology       Date:  1999-04-25       Impact factor: 3.616

5.  Clustered genes for human U2 RNA.

Authors:  G Westin; J Zabielski; K Hammarström; H J Monstein; C Bark; U Pettersson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Nucleotide sequence of a segment of human DNA containing the three tRNA genes.

Authors:  K L Roy; H Cooke; R Buckland
Journal:  Nucleic Acids Res       Date:  1982-11-25       Impact factor: 16.971

7.  Replication and pathogenicity of primer binding site mutants of SL3-3 murine leukemia viruses.

Authors:  A H Lund; J Schmidt; A Luz; A B Sørensen; M Duch; F S Pedersen
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

8.  The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA.

Authors:  S Cen; Y Huang; A Khorchid; J L Darlix; M A Wainberg; L Kleiman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

9.  Nucleotide sequence of three isoaccepting lysine tRNAs from rabbit liver and SV40-transformed mouse fibroblasts.

Authors:  M Raba; K Limburg; M Burghagen; J R Katze; M Simsek; J E Heckman; U L Rajbhandary; H J Gross
Journal:  Eur J Biochem       Date:  1979-06

10.  Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.

Authors:  T Schnell; P Foley; M Wirth; J Münch; K Uberla
Journal:  Hum Gene Ther       Date:  2000-02-10       Impact factor: 5.695

View more
  2 in total

1.  Reduced mobilization of Rev-responsive element-deficient lentiviral vectors.

Authors:  Susann Lucke; Thomas Grunwald; Klaus Uberla
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

2.  Atraumatic oral spray immunization with replication-deficient viral vector vaccines.

Authors:  Christiane Stahl-Hennig; Seraphin Kuate; Monika Franz; You S Suh; Heribert Stoiber; Ulrike Sauermann; Klara Tenner-Racz; Stephen Norley; Ki S Park; Young C Sung; Ralph Steinman; Paul Racz; Klaus Uberla
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.